What: Shares of Galena Biopharma (NASDAQ: GALE), a clinical-stage biopharmaceutical company focused on the development of therapies to treat cancer, soared 31% in May, according to data from S&P Global Market Intelligence. Two things in particular helped push Galena substantially higher during the month.